top of page
Dr. Seth Bechis on the BackTable Urology Podcast

Dr. Seth Bechis

Urologist

1 Podcast on BackTable

Dr. Seth Bechis is a practicing urologist and associate professor with UC San Diego in California.

Learn from the experiences and expertise of Dr. Seth Bechis and other leading voices in your specialty on the BackTable app.

Treating BPH with Rezum
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Urology

Episode # 101  •  07 Jun 2023

Treating BPH with Rezum

This week on the BackTable Urology Podcast, Dr. Jose Silva invites Dr. Seth Bechis onto the show to discuss the diagnosis and treatment of BPH with Rezum, a minimally invasive surgical that uses water vapor to dissolve prostate tissue.

This podcast is supported by

Boston Scientific Rezum Water Vapor Therapy

More from Dr. Seth Bechis

About

Seth Bechis, MD, is a board-certified urologist who cares for patients with diseases of the urinary tract, including kidney stones, benign prostatic hyperplasia (BPH) or enlarged prostate, and men's health issues. As a member of the Comprehensive Kidney Stone Center at UC San Diego Health, he has a special interest in advanced surgical treatment, medical prevention, and research on kidney stone disease. He has surgical expertise in percutaneous nephrolithotomy (PCNL) for complex stones, ureteroscopy and shockwave lithotripsy.

Dr. Bechis specializes in all procedures of the prostate including minimally invasive procedures such as Rezum water vapor therapy and UroLift, as well as robotic surgery and GreenLight™ Laser photoselective vaporization of the prostate (PVP).

Dr. Bechis is among only a select number of physicians in the country to be designated as a Center of Excellence for GreenLight™ Laser Therapy. He is the first in California to achieve this recognition which marks a high degree of experience with GreenLight™ Laser Therapy and commitment to delivering effective, long-lasting therapy to men suffering from BPH.
As a urologist at an academic medical center, Dr. Bechis is involved in teaching and education. He also serves as the associate program director for the UC San Diego - Kaiser Laparoscopy/Endourology Fellowship in the Department of Urology at UC San Diego School of Medicine. His previous research includes the study of molecular pathways in the progression of benign prostatic hyperplasia, risk factors for stone formation, and analysis of age and other risk factors on predicting prostate cancer-specific survival. His current research includes improving surgical techniques and clinical outcomes in stone disease, as well as tools for stone diagnosis and opiate-sparing pathways for managing pain. His research has been featured in peer-reviewed medical journals, including Journal of Urology, Journal of Endourology, and World Journal of Urology. Additionally, he was editor of First Aid Q&A for the USMLE Step 1, Second Edition and has authored chapters for university handbooks.

Prior to joining UC San Diego Health, Dr. Bechis worked at Massachusetts General Hospital and Harvard Medical School, where he taught residents and medical students in the operating room and clinic. Dr. Bechis has won numerous awards and honors over the years, including the Whitehill Award for Excellence in Clinical Teaching in 2019, Plenary Address for Best Abstract from the American Urological Association in 2015, and first place in the 2014 Max K. Willscher Resident Research Award Competition. He has been invited to speak nationally and internationally at conferences on topics including benign prostatic hyperplasia and stone disease.

Dr. Bechis completed fellowship training in laparoscopy/robotics and endourology at UC San Diego School of Medicine, and residency training at Harvard Medical School, Massachusetts General Hospital. He earned his medical degree from the University of California, San Francisco School of Medicine and holds additional Master of Science training in biomedical research, also from UCSF. Biomedical research (or experimental medicine) focuses on ways to prevent and treat diseases. It is a key component of the Comprehensive Kidney Stone Center, which offers patients access to clinical trials that examine newly developed therapies and procedures.

Dr. Bechis is a member of several professional medical organizations, including the American Urological Association (AUA), the Endourological Society, and the Western Section of the AUA.

Visit UC San Diego Health to learn more about Dr. Seth Bechis.

This BackTable podcast is sponsored by Boston Scientific’s Urology Division. Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world; this includes solutions for Benign Prostatic Hyperplasia or BPH, one of the most prevalent urologic conditions facing men today. [1,2]

Boston Scientific’s RezūmTM Water Vapor Therapy is a minimally invasive BPH treatment that provides urologists with an efficient, durable solution that reduces prostate volume while preserving sexual function. [3,4] With proven efficacy, durability, and lower clinical progression rates than daily medications, AUA guidelines support a shared decision-making process for the consideration of RezūmTM as a first-line treatment and alternative to medications. [3,5,6] Additionally, if insufficiently treated, BPH can negatively impact bladder function, making earlier intervention valuable for patients. [7] Give your patients an alternative to daily medications and long-lasting BPH relief with Rezum Therapy.

1. AUA Annual Census Report – 2021, https://www.auanet.org/research-and-data/aua-census
2. Chughtai B, Forde JC, Thomas DD, Laor L, Hossack T, Woo HH, Te AE, Kaplan SA. Benign prostatic hyperplasia. Nat Rev Dis Primers. 2016 May 5;2:16031. doi: 10.1038/nrdp.2016.31. PMID: 27147135
3. McVary KT, Gittelman MC, Goldberg KA, et al. Final 5-year outcomes of the multicenter randomized sham-controlled trial of Rezūm water vapor thermal therapy for treatment of moderate-to-severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2021 Sep;206(3):715-24.
4. Mynderse LA, Hanson D, Robb RA, et al. Rezūm System water vapor treatment for lower urinary tract symptoms/benign prostatic hyperplasia: validation of convective thermal energy transfer and characterization with magnetic resonance imaging and 3-dimensional renderings. Urology. 2015 Jul;86(1):122-7.
5. Gupta N, Rogers T, Holland B, et al. Three-year treatment outcomes of water vapor thermal therapy (Rezūm System) compared to doxazosin, finasteride and combination drug therapy for men with benign prostatic hyperplasia: cohort data from the Medical Therapy of Prostatic Symptoms (MTOPS) Trial. J Urol. 2018 Aug;200(2):405-13.
6. Lerner LB, McVary, KT, Barry MJ et al: Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline. J Urol 2021; 206: 806.
7. Mirone V, Imbimbo C, Longo N, Fusco F. The Detrusor Muscle: An Innocent Victim of Bladder Outlet Obstruction. J Eur Uro. 2007, Vol 51

Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
All trademarks are the property of their respective owners.
©2023 Boston Scientific Corporation or its affiliates. All rights reserved. URO-1540313-AA MAR 2023

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page